Cargando…
The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types
For many years, defects in the ribosome have been associated to cancer. Recently, somatic mutations and deletions affecting ribosomal protein genes were identified in a few leukemias and solid tumor types. However, systematic analysis of all 81 known ribosomal protein genes across cancer types is la...
Autores principales: | Fancello, Laura, Kampen, Kim R., Hofman, Isabel J.F., Verbeeck, Jelle, Keersmaecker, Kim De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362418/ https://www.ncbi.nlm.nih.gov/pubmed/28147343 http://dx.doi.org/10.18632/oncotarget.14895 |
Ejemplares similares
-
The T-cell leukemia associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling
por: Girardi, Tiziana, et al.
Publicado: (2017) -
Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL
por: Kampen, Kim R., et al.
Publicado: (2019) -
RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response
por: Hofman, Isabel JF, et al.
Publicado: (2016) -
The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2
translation in T-ALL
por: Kampen, Kim R., et al.
Publicado: (2018) -
Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway
por: Franklin, Derek A., et al.
Publicado: (2022)